Investigational drugs for the treatment of COVID-19

The adverse reactions of the following drugs, which are under consideration or investigation for the treatment of patients with COVID-19, are searchable in Litt’s Drug Eruption & Reaction Database.

Other drugs developed before the emergence of Covid-19 (e.g. Remdesvir) are also under investigation for treating this disease, but are not yet approved by the FDA for other indications and therefore are not included in the Litt database. The drugs Cobicistat and Ritonavir are under investigation for treating Covid-19, but in combinations that are not yet included here.